A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 35778
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PD
Long Form : Parkinson's disease
No. Year Title Co-occurring Abbreviation
2019 "Will you draw me a pelvis?ˮ Dynamic neuro-cognitive imagery improves pelvic schema and graphic-metric representation in people with Parkinson's Disease: A randomized controlled trial. DNI
2019 (E)-Nicotinaldehyde O-Cinnamyloxime, a Nicotine Analog, Attenuates Neuronal Cells Death Against Rotenone-Induced Neurotoxicity. CNS, nAChR, ROS
2019 17 beta-Estradiol Oxidative Stress Attenuation and Autophagy-Induced Dopaminergic Neuroprotection. LC3, OCG, RT-PCR, ULK1
2019 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease. BPND, DAT, HVs, mGluR5
2019 22q11.2 Deletion Syndrome-Associated Parkinson's Disease. 22q11.2DS
2019 3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing. Inh2
2019 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2∗ maps. HC, QSM, SN
2019 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress. MPTP, SN, TH, THP-Ms
2019 5-HT2A blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review. L-DOPA, MPTP, PLBs
10  2019 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease. 5hmC, 5mC, MSA
11  2019 50-Hz MF does not affect global DNA methylation of SH-SY5Y cells treated with the neurotoxin MPP. 5mC, ELF-MFs
12  2019 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. 5AR, D1R, DUTA, ERK, FIN, LID
13  2019 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat. CS, LDH, NAC, ROS
14  2019 7,8,4'-Trihydroxyisoflavone, a Metabolized Product of Daidzein, Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells. CAT, GSK-3beta, JNK, LDH, MAPK, MDA, PARP, PI3K, SOD, TH, THIF
15  2019 7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents. 7,8-DHF, SN
16  2019 7.0T ultrahigh-field MRI directly visualized the pedunculopontine nucleus in Parkinson's disease patients. DBS, MRI, PPN
17  2019 A baseline study for detection of Parkinson's disease with 3D-transcranial sonography and uni-lateral reconstruction. ---
18  2019 A clinical process redesign project to improve outcomes and reduce care variance for people with Parkinson's disease. ED
19  2019 A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging. DBM, PLS
20  2019 A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein alpha-Synuclein. IDPs
21  2019 A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey. HADS, MSA, VAS
22  2019 A comparison of visual hallucinations across disorders. ED, LBD, MSH, VH
23  2019 A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. SNc, STN
24  2019 A CRISPR monkey model unravels a unique function of PINK1 in primate brains. ---
25  2019 A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment. PD-MCI
26  2019 A hidden Markov model addressing measurement errors in the response and replicated covariates for continuous nondecreasing processes. ---
27  2019 A High-Intensity Exercise Boot Camp for Persons With Parkinson Disease: A Phase II, Pragmatic, Randomized Clinical Trial of Feasibility, Safety, Signal of Efficacy, and Disease Mechanisms. BDNF, CDC, HIBC, UC
28  2019 A Multi-layer Gaussian Process for Motor Symptom Estimation in People with Parkinson's Disease. PWP
29  2019 A National Snapshot Detailing the Impact of Parkinson's Disease on the Cost and Outcome Profiles of Fusion Procedures for Cervical Myelopathy. CM
30  2019 A Nationwide Survey of Parkinson's Disease Medicines Availability and Affordability in Nigeria. ---
31  2019 A New Metabolic Network Correlated with Olfactory and Executive Dysfunctions in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. DATs, HC, PDRBD-RP, REM
32  2019 A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification. GA, MPTP, NHP
33  2019 A Non-Invasive Medical Device for Parkinson's Patients with Episodes of Freezing of Gait. FOG
34  2019 A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson's disease models. ---
35  2019 A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression. ACM, HO-1, KO, PGD2, TNF-alpha, WT
36  2019 A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases. AD
37  2019 A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein. ---
38  2019 A proteomic signature for dementia with Lewy bodies. DLB
39  2019 A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease. ---
40  2019 A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson's Disease. BDI, UPDRS
41  2019 A ReliefF-SVM-based method for marking dopamine-based disease characteristics: A study on SWEDD and Parkinson's disease. SWEDD
42  2019 A review for the pharmacological effect of lycopene in central nervous system disorders. AD, BDNF, Cd, CNS, HD, HFD, JNK, MSG, NF-kappaB, Nrf2, TBHP, TMT
43  2019 A Review of Biomarkers Use in Parkinson with Deep Brain Stimulation: A Successful Past Promising a Bright Future. DBS
44  2019 A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies. ---
45  2019 A search for cortical correlates of trait impulsivity in Parkinsons disease. CCF, CT, HC, ICD, MRI
46  2019 A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease. SE
47  2019 A survey on computer-assisted Parkinson's Disease diagnosis. ACM, MDPI
48  2019 A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease. ---
49  2019 A systematic review and meta-analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders. AD, FEMs, REMs, VDR
50  2019 A systematic review of MEG-based studies in Parkinson's disease: The motor system and beyond. MEG
51  2019 A30P mutant alpha-synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons. p-JNK
52  2019 AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease. alpha-syn-WT, DA, GFP, SNpc
53  2019 Aberrant functional connectivity in patients with Parkinson's disease and freezing of gait: a within- and between-network analysis. FOG, HS, PD-FOG, RSFC, RSNs
54  2019 Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study. AAL, MEG, PF, VH
55  2019 Abnormal alpha-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility. DLB, MSA-P, RBD, SFN
56  2019 Abnormal Dynamic Functional Connectivity Associated With Subcortical Networks in Parkinson's Disease: A Temporal Variability Perspective. fMRI, NCs
57  2019 Abnormal Eye Movements in Parkinsonism and Movement Disorders. SP
58  2019 Abnormal Phase Coupling in Parkinson's Disease and Normalization Effects of Subthreshold Vestibular Stimulation. BG, DBS, EVS, HC, NIBS, PLV
59  2019 Abnormal phasic activity in saliency network, motor areas, and basal ganglia in Parkinson's disease during rhythm perception. ---
60  2019 Abundance of Synaptic Vesicle-Related Proteins in Alpha-Synuclein-Containing Protein Inclusions Suggests a Targeted Formation Mechanism. DLB, GCIs, MSA
61  2019 Accelerated accumulation of retinal alpha-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease. CNS
62  2019 Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson's disease. CI, MDS-UPDRS, UPDRS, WDMA
63  2019 Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis. TCS
64  2019 Acoustic Voice Modifications in Individuals with Parkinson Disease Submitted to Deep Brain Stimulation. ---
65  2019 Activation and blockade of serotonin4 receptors in the lateral habenula improve working memory in unilateral 6-hydroxydopamine-lesioned Parkinson's rats. DA, LHb, NA, SNc
66  2019 Activation of alpha7-nAChRs protects SH-SY5Y cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death via ERK/p53 signaling pathway. alpha7 nAChRs, ERK
67  2019 Activation of the immunoproteasome protects SH-SY5Y cells from the toxicity of rotenone. i-proteasome
68  2019 Active information storage in Parkinson's disease: a resting state fMRI study over the sensorimotor cortex. AIS, fALFF, rs-fMRI
69  2019 Activities of Daily Living and Their Relationship to Health-Related Quality of Life in Patients with Parkinson Disease After Subthalamic Nucleus Deep Brain Stimulation. ADL, DBS, HRQoL, PDQ-39, STN
70  2019 Acupuncture Alleviates Levodopa-Induced Dyskinesia via Melanin-Concentrating Hormone in Pitx3-Deficient aphakia and 6-Hydroxydopamine-Lesioned Mice. AIMs, L-DOPA, LID, PMCH
71  2019 Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model. MPTP, SGK1, SN
72  2019 Acute inflammation down-regulates alpha-synuclein expression in enteric neurons. ENS
73  2019 Adapted Feeding Utensils for People With Parkinson's-Related or Essential Tremor. ET
74  2019 Administration of resveratrol improved Parkinson's disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1/miR-129/SNCA signaling pathway. MALAT1
75  2019 Administration of tetrahydrobiopterin restored the decline of dopamine in the striatum induced by an acute action of MPTP. MPTP, Qdpr, TH
76  2019 Admixing MPTP-resistant and MPTP-vulnerable mice enhances striatal field potentials and calbindin-D28K expression to avert motor behaviour deficits. LFPs, MPTP
77  2019 Advances in Management of Psychosis in Neurodegenerative Diseases. AChI, AD, NDD, NPS
78  2019 Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease. ---
79  2019 Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive-compulsive disorder. OCD, STN
80  2019 Age and time course of long-term motor and nonmotor complications in Parkinson disease. ---
81  2019 Age- and alpha-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri. ---
82  2019 Age-dependent accumulation of oligomeric SNCA/alpha-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). CMA, KI, LRRK2, MEFs, WT
83  2019 Aging mildly affects dendritic arborisation and synaptic protein expression in human substantia nigra pars compacta. SNpc
84  2019 Aging, rather than Parkinson's disease, affects the responsiveness of PBMCs to the immunosuppression of bone marrow mesenchymal stem cells. IFN, IL, PBMCs, TNF
85  2019 Air pollution and Parkinson's disease: A systematic review and meta-analysis up to 2018. CI, RR
86  2019 ALDH1A1 regulates postsynaptic mu-opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling. ALDH1A1, nDA, Pitx3, RA
87  2019 Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD). RBD
88  2019 alpha-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? ---
89  2019 alpha-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys. alpha-syn, MPTP, SN, TH
90  2019 Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease. alpha-Syn, LP, SNc
91  2019 Alpha-Synuclein Is a Target of Fic-Mediated Adenylylation/AMPylation: Possible Implications for Parkinson's Disease. alpha-Syn, ER, PTM, UPR
92  2019 alpha-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis. ---
93  2019 alpha-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-beta1 signaling in a Parkinson's disease model. TGF-beta1
94  2019 Alpha-Synuclein RNA Expression is Increased in Major Depression. MDD, SNCA
95  2019 Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. alpha-Syn, ClpP, DA, SOD2
96  2019 Alterations of Sleep and Sleep Oscillations in the Hemiparkinsonian Rat. EEG, HIPP, HVS, MCx, SNpc, SSs
97  2019 Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers. HC, miRNAs, NDC, Nurr1, RT-qPCR
98  2019 Altered functional connectivity of the marginal division in Parkinson's disease with mild cognitive impairment: A pilot resting-state fMRI study. FC, HC, MCI, MrD, PD-NCI, rs-fMRI
99  2019 Altered functional network topology correlates with clinical measures in very early-stage, drug-naive Parkinson's disease. ---
100  2019 Altered gastric tone and motility response to brainstem dopamine in a rat model of parkinsonism. DA, DMV, GI, PQ